An AT1R antagonist attenuates the fibrosis development in pig serum-induced liver fibrosis in rats by blocking the expression of TGF-β mRNA, which is increased by locally produced angiotensin II in the activated HSCs [21]. Here, AGTR1 is linked to Hepatic fibrosis.